Overview
Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association.
Dr. Lammi is rated as an Experienced provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Pulmonary Hypertension, Sarcoidosis, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Lung Transplant.
His clinical research consists of co-authoring 74 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Pneumonia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4940 Eastern Avenue, Bayview Medical Offices, Level 01 (G), Clinic 5, Bayview Medical Offices, Level 01 (G), Clinic 5, Baltimore, MD 21224
5501 Hopkins Bayview Circle, Floor 1, Baltimore, MD 21224
Additional Areas of Focus
Dr. Lammi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Medstar Medical Group Ii LLC
Andrew Shorr is a Pulmonary Medicine provider in Washington, Washington, D.c.. Dr. Shorr is rated as a Distinguished provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Pneumonia, Hospital-Acquired Pneumonia, Hypovolemic Shock, Chronic Obstructive Pulmonary Disease (COPD), and Gastrostomy. Dr. Shorr is currently accepting new patients.
Inova Health Care Services
Steven Nathan is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Falls Church, Virginia. Dr. Nathan is rated as an Elite provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Prostatectomy. Dr. Nathan is currently accepting new patients.
Johns Hopkins Bayview Medical Center
Dr. Danoff is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and Co-Director of the Hopkins Interstitial Lung Disease Clinic. She is a specialist in diseases causing fibrosis or scarring in the lung, particularly those associated with autoimmune diseases including myositis. Dr. Danoff is rated as an Elite provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Endoscopy, and Lung Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Pulmonary HypertensionDr. Lammi isElite. Learn about Pulmonary Hypertension.
- SarcoidosisDr. Lammi isElite. Learn about Sarcoidosis.
- Distinguished
- Systemic Sclerosis (SSc)Dr. Lammi isDistinguished. Learn about Systemic Sclerosis (SSc).
- Advanced
- Acute Interstitial PneumoniaDr. Lammi isAdvanced. Learn about Acute Interstitial Pneumonia.
- Cerebral HypoxiaDr. Lammi isAdvanced. Learn about Cerebral Hypoxia.
- Chronic Obstructive Pulmonary Disease (COPD)
- Interstitial Lung DiseaseDr. Lammi isAdvanced. Learn about Interstitial Lung Disease.
- NeurosarcoidosisDr. Lammi isAdvanced. Learn about Neurosarcoidosis.
- Pulmonary Veno-Occlusive Disease
- Experienced
- AsthmaDr. Lammi isExperienced. Learn about Asthma.
- Asthma in ChildrenDr. Lammi isExperienced. Learn about Asthma in Children.
- EmphysemaDr. Lammi isExperienced. Learn about Emphysema.
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- Idiopathic Pulmonary FibrosisDr. Lammi isExperienced. Learn about Idiopathic Pulmonary Fibrosis.
- Lung MetastasesDr. Lammi isExperienced. Learn about Lung Metastases.